{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:29:36Z","timestamp":1783463376198,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.arth.2016.11.021","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T08:19:51Z","timestamp":1479889191000},"page":"1089-1094.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Should Preoperative Antibiotics Be Tailored According to Patient's Comorbidities and Susceptibility to Organisms?"],"prefix":"10.1016","volume":"32","author":[{"given":"Timothy L.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell G.","family":"Maltenfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-8188","authenticated-orcid":false,"given":"Antonia F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2016.11.021_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.arth.2016.11.021_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0196-6553(99)70088-X","article-title":"Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control And Prevention (CDC) Hospital Infection Control Practices Advisory Committee","volume":"27","author":"Mangram","year":"1999","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.arth.2016.11.021_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arth.2013.09.030","article-title":"Perioperative antibiotics","volume":"29","author":"Hansen","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"issue":"10","key":"10.1016\/j.arth.2016.11.021_bib4","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.2106\/JBJS.H.01219","article-title":"Prophylactic antibiotics in hip and knee arthroplasty","volume":"91","author":"Meehan","year":"2009","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2016.11.021_bib6","series-title":"Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty","year":"2004"},{"key":"10.1016\/j.arth.2016.11.021_bib7","series-title":"Surgical site infection: prevention and treatment of surgical site infection","article-title":"National Institute for Health and Clinical Excellence (NICE) guidance","year":"2008"},{"issue":"3-4","key":"10.1016\/j.arth.2016.11.021_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"10.1016\/j.arth.2016.11.021_bib9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2106\/JBJS.K.00072","article-title":"Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in medicare patients","volume":"94","author":"Bozic","year":"2012","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.arth.2016.11.021_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11999-011-2043-3","article-title":"Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA","volume":"470","author":"Bozic","year":"2012","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.arth.2016.11.021_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.arth.2013.04.015","article-title":"Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study","volume":"29","author":"Bozic","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2016.11.021_bib12","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.arth.2016.11.021_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejim.2010.02.006","article-title":"Preoperative hyperglycemia predicts infected total knee replacement","volume":"21","author":"Jamsen","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.arth.2016.11.021_bib14","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s11999-014-3593-y","article-title":"Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty","volume":"472","author":"Jiang","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2016.11.021_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.arth.2016.11.021_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2016.11.021_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arth.2013.09.028","article-title":"Mitigation and education","volume":"29","author":"Aggarwal","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2016.11.021_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arth.2011.03.044","article-title":"Prosthetic joint infection caused by Gram-negative organisms","volume":"26","author":"Zmistowski","year":"2011","journal-title":"J\u00a0Arthroplasty"},{"issue":"6","key":"10.1016\/j.arth.2016.11.021_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/00016470310018135","article-title":"Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register","volume":"74","author":"Engesaeter","year":"2003","journal-title":"Acta Orthop Scand"},{"issue":"8 Suppl","key":"10.1016\/j.arth.2016.11.021_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arth.2012.03.040","article-title":"Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients?","volume":"27","author":"Smith","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2016.11.021_bib21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/AAC.06246-11","article-title":"Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?","volume":"56","author":"Peel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.arth.2016.11.021_bib22","first-page":"247","article-title":"Vancomycin prophylaxis in joint arthroplasty","volume":"84","author":"Savarese","year":"1999","journal-title":"Chir Organi Mov"},{"key":"10.1016\/j.arth.2016.11.021_bib23","first-page":"2125","article-title":"Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment","volume":"32","author":"Bassetti","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.arth.2016.11.021_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/ket351","article-title":"Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-\u03b1 inhibitor therapy","volume":"53","author":"Varley","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.arth.2016.11.021_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.21841","article-title":"Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis","volume":"55","author":"Giles","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.arth.2016.11.021_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/s10165-011-0423-x","article-title":"Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs","volume":"21","author":"Momohara","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.arth.2016.11.021_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy induced neutropenia","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.arth.2016.11.021_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1054\/arth.2001.19159","article-title":"Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases","volume":"16","author":"Yang","year":"2001","journal-title":"J\u00a0Arthroplasty"},{"issue":"3","key":"10.1016\/j.arth.2016.11.021_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0883-5403(06)80090-2","article-title":"Total hip arthroplasty in patients with diabetes mellitus","volume":"8","author":"Moeckel","year":"1993","journal-title":"J\u00a0Arthroplasty"},{"issue":"18","key":"10.1016\/j.arth.2016.11.021_bib30","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.2106\/JBJS.K.00318","article-title":"Mycoplasma pneumoniae periprosthetic joint infection identified by 16S ribosomal RNA gene amplification and sequencing: a case report","volume":"93","author":"Han","year":"2011","journal-title":"J\u00a0Bone Joint Surg Am"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088354031630821X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088354031630821X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T13:00:33Z","timestamp":1601211633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088354031630821X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S088354031630821X"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2016.11.021","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Preoperative Antibiotics Be Tailored According to Patient's Comorbidities and Susceptibility to Organisms?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2016.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}